NCT04119024 2026-03-17Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsStanford UniversityPhase 1 Recruiting18 enrolled
NCT04459273 2026-02-05FAPI PET RDRCJonsson Comprehensive Cancer CenterPhase 1 Active not recruiting26 enrolled
NCT07118176 2025-08-12Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersJonsson Comprehensive Cancer CenterPhase 1 Recruiting30 enrolled
NCT06815029 2025-06-26Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant AstrocytomaCity of Hope Medical CenterPhase 1 Recruiting27 enrolled
NCT01246869 2024-10-01Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and WaterUniversity of UtahPhase 1 Terminated2 enrolled
NCT00813566 2022-04-27Multi-Tracer PET Assessment of Primary Brain TumorsUniversity of UtahPhase 1 Completed11 enrolled